Heart Pharmacology

Cardiovascular pharmacology manages the medicine of heart maladies. The Cardiac Drugs are utilized to treat states of the identified with heart or the circulatory or vascular science . Numerous classes of cardiovascular specialists are accessible to treat the different cardiovascular conditions. The most usually utilized sub-classification drugs incorporate Sodium, potassium, calcium channel blockers, ACE-inhibitors and Cardiac biomarkers. There are predominantly 6 affiliations and social orders and the principle relationship for Cardiac Therapeutic Agents in USA. 50 colleges are taking a shot at Cardiac Therapeutic Agents. As of late three new medications were presented in 2015. There are numerous kinds of cardiovascular medications in the market that incorporate Cardiac glycosides, enemies of coagulants, against arrhythmic operators, hostile to anginal specialists and against hypertensive specialists.

 

  • Drug-Induced Cardiac Toxicity
  • Novel Anti-Inflammatory Therapies for Atherosclerosis
  • Development of Novel Anti-Ischaemic Agents
  • Beta Blockers Blocking
  • Cardiac Glycoside

Related Conference of Heart Pharmacology

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland
October 30-31, 2024

7th Global Cardiovascular Research and Clinical Cardiology

Vancouver, Canada

Heart Pharmacology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in